|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 February 2001, Vol. 97, No. 4, pp. 1144-1146
BRIEF REPORT
Specialized roles of the chemokine receptors CCR1 and CCR5 in the
recruitment of monocytes and TH1-like/CD45RO+
T cells
Christian Weber,
Kim S. C. Weber,
Christiane Klier,
Songhai Gu,
Rudolf Wank,
Richard Horuk, and
Peter J. Nelson
From the Institut für Prophylaxe der
Kreislaufkrankheiten, Medizinische Poliklinik, and Institut für
Immunologie, Ludwig-Maximilians-Universität München,
Munich, Germany; and Berlex Biosciences, Richmond, CA.
Chemokines and their receptors control the emigration of leukocytes
during inflammation. The role of the RANTES (regulated on activation
normal T-cell expressed and secreted) receptors CCR1 and CCR5
in the selective recruitment of monocytes, TH1-like T-cell
clones, and peripheral T cells enriched for CD45RO+
"memory" cells were tested in a system in which arrest under flow
conditions is triggered by RANTES immobilized to activated endothelium.
With the use of selective nonpeptide receptor antagonists or blocking
antibodies, it was found that the RANTES-induced arrest of these cells
was mediated predominantly by CCR1. In contrast, CCR5 mainly
contributed to the spreading in shear flow, and both CCR1 and CCR5
supported transendothelial chemotaxis toward RANTES. The data in this
study reveal specialized roles of apparently redundant receptors in
distinct steps of leukocyte trafficking and suggest that not all
receptors currently used to define mononuclear cell subsets are
involved in their direct recruitment from the circulation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. M. van Gils, J. J. Zwaginga, and P. L. Hordijk
Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases
J. Leukoc. Biol.,
February 1, 2009;
85(2):
195 - 204.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Schober
Chemokines in Vascular Dysfunction and Remodeling
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2008;
28(11):
1950 - 1959.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Bendz, B.-C. Marincek, F. Momburg, J. W. Ellwart, R. D. Issels, P. J. Nelson, and E. Noessner
Calcium Signaling in Dendritic Cells by Human or Mycobacterial Hsp70 Is Caused by Contamination and Is Not Required for Hsp70-mediated Enhancement of Cross-presentation
J. Biol. Chem.,
September 26, 2008;
283(39):
26477 - 26483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Okada, T. Kondo, F. Matsuki, H. Takata, and M. Takiguchi
Phenotypic classification of human CD4+ T cell subsets and their differentiation
Int. Immunol.,
September 1, 2008;
20(9):
1189 - 1199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Braunersreuther, S. Steffens, C. Arnaud, G. Pelli, F. Burger, A. Proudfoot, and F. Mach
A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2008;
28(6):
1090 - 1096.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Byers, E. Sakhinia, P. Joseph, C. Glennie, J. A. Hoyland, L. P. Menasce, J. A. Radford, and T. Illidge
Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling
Blood,
May 1, 2008;
111(9):
4764 - 4770.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Montecucco, F. Burger, F. Mach, and S. Steffens
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
Am J Physiol Heart Circ Physiol,
March 1, 2008;
294(3):
H1145 - H1155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Schaller, L. E. Kallal, and N. W. Lukacs
A Key Role for CC Chemokine Receptor 1 in T-Cell-Mediated Respiratory Inflammation
Am. J. Pathol.,
February 1, 2008;
172(2):
386 - 394.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Krohn, U. Raffetseder, I. Bot, A. Zernecke, E. Shagdarsuren, E. A. Liehn, P. J. van Santbrink, P. J. Nelson, E. A. Biessen, P. R. Mertens, et al.
Y-Box Binding Protein-1 Controls CC Chemokine Ligand-5 (CCL5) Expression in Smooth Muscle Cells and Contributes to Neointima Formation in Atherosclerosis-Prone Mice
Circulation,
October 16, 2007;
116(16):
1812 - 1820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Sato, T. Aranami, and T. Yamamura
Cutting Edge: Human Th17 Cells Are Identified as Bearing CCR2+CCR5- Phenotype
J. Immunol.,
June 15, 2007;
178(12):
7525 - 7529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Mayer, K. L. Hudkins, F. Heller, H. Schmid, M. Kretzler, U. Brandt, H.-J. Anders, H. Regele, P. J. Nelson, C. E. Alpers, et al.
Expression of the chemokine receptor CCR1 in human renal allografts
Nephrol. Dial. Transplant.,
June 1, 2007;
22(6):
1720 - 1729.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Segerer, R. Djafarzadeh, H.-J. Grone, C. Weingart, D. Kerjaschki, C. Weber, A. J. Kungl, H. Regele, A. E.I. Proudfoot, and P. J. Nelson
Selective Binding and Presentation of CCL5 by Discrete Tissue Microenvironments during Renal Inflammation
J. Am. Soc. Nephrol.,
June 1, 2007;
18(6):
1835 - 1844.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Cho, P. Shashkin, C. A. Gleissner, D. Dunson, N. Jain, J. K. Lee, Y. Miller, and K. Ley
Induction of dendritic cell-like phenotype in macrophages during foam cell formation
Physiol Genomics,
April 24, 2007;
29(2):
149 - 160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Cavusoglu, C. Eng, V. Chopra, L. T. Clark, D. J. Pinsky, and J. D. Marmur
Low Plasma RANTES Levels Are an Independent Predictor of Cardiac Mortality in Patients Referred for Coronary Angiography
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2007;
27(4):
929 - 935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Braunersreuther, A. Zernecke, C. Arnaud, E. A. Liehn, S. Steffens, E. Shagdarsuren, K. Bidzhekov, F. Burger, G. Pelli, B. Luckow, et al.
Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2007;
27(2):
373 - 379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Zernecke, E. A. Liehn, J.-L. Gao, W. A. Kuziel, P. M. Murphy, and C. Weber
Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10
Blood,
June 1, 2006;
107(11):
4240 - 4243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Puneet, A. Hegde, S. W. Ng, H. Y. Lau, J. Lu, S. M. Moochhala, and M. Bhatia
Preprotachykinin-A Gene Products Are Key Mediators of Lung Injury in Polymicrobial Sepsis
J. Immunol.,
March 15, 2006;
176(6):
3813 - 3820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. J. Crane, H. Xu, C. Wallace, A. Manivannan, M. Mack, J. Liversidge, G. Marquez, P. F. Sharp, and J. V. Forrester
Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis
J. Leukoc. Biol.,
March 1, 2006;
79(3):
435 - 443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J J Haringman, T J M Smeets, P Reinders-Blankert, and P P Tak
Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis
Ann Rheum Dis,
March 1, 2006;
65(3):
294 - 300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Notohamiprodjo, R. Djafarzadeh, A. Mojaat, I. von Luttichau, H.-J. Grone, and P. J. Nelson
Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation
Protein Eng. Des. Sel.,
January 1, 2006;
19(1):
27 - 35.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Reichel, A. Khandoga, H.-J. Anders, D. Schlondorff, B. Luckow, and F. Krombach
Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue
J. Leukoc. Biol.,
January 1, 2006;
79(1):
114 - 122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Weber
Killing Two Birds With One Stone: Targeting Chemokine Receptors in Atherosclerosis and HIV Infection
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2005;
25(12):
2448 - 2450.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Baltus, P. von Hundelshausen, S. F. Mause, W. Buhre, R. Rossaint, and C. Weber
Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions
J. Leukoc. Biol.,
August 1, 2005;
78(2):
435 - 441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Ninichuk, O. Gross, C. Reichel, A. Khandoga, R. D. Pawar, R. Ciubar, S. Segerer, E. Belemezova, E. Radomska, B. Luckow, et al.
Delayed Chemokine Receptor 1 Blockade Prolongs Survival in Collagen 4A3-Deficient Mice with Alport Disease
J. Am. Soc. Nephrol.,
April 1, 2005;
16(4):
977 - 985.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. L. de Mendonca, P. C. A. da Fonseca, R. M. Phillips, J. W. Saldanha, T. J. Williams, and J. E. Pease
Site-directed Mutagenesis of CC Chemokine Receptor 1 Reveals the Mechanism of Action of UCB 35625, a Small Molecule Chemokine Receptor Antagonist
J. Biol. Chem.,
February 11, 2005;
280(6):
4808 - 4816.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. von Hundelshausen, R. R. Koenen, M. Sack, S. F. Mause, W. Adriaens, A. E. I. Proudfoot, T. M. Hackeng, and C. Weber
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
Blood,
February 1, 2005;
105(3):
924 - 930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-J. Anders, V. Vielhauer, and D. Schlondorff
Current paradigms about chemokines as therapeutic targets
Nephrol. Dial. Transplant.,
December 1, 2004;
19(12):
2948 - 2951.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Weber, A. Schober, and A. Zernecke
Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2004;
24(11):
1997 - 2008.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J J Haringman, J Ludikhuize, and P P Tak
Chemokines in joint disease: the key to inflammation?
Ann Rheum Dis,
October 1, 2004;
63(10):
1186 - 1194.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Simeoni, B. R. Winkelmann, M. M. Hoffmann, S. Fleury, J. Ruiz, L. Kappenberger, W. Marz, and G. Vassalli
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis
Eur. Heart J.,
August 2, 2004;
25(16):
1438 - 1446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. da Costa Santiago, C. F. Oliveira, L. Santiago, F. Oliveira Ferraz, D. da Gloria de Souza, L. A. Rodrigues De-Freitas, L. C. Crocco Afonso, M. M. Teixeira, R. T. Gazzinelli, and L. Q. Vieira
Involvement of the Chemokine RANTES (CCL5) in Resistance to Experimental Infection with Leishmania major
Infect. Immun.,
August 1, 2004;
72(8):
4918 - 4923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-J. Anders, E. Belemezova, V. Eis, S. Segerer, V. Vielhauer, G. P. de Lema, M. Kretzler, C. D. Cohen, M. Frink, R. Horuk, et al.
Late Onset of Treatment with a Chemokine Receptor CCR1 Antagonist Prevents Progression of Lupus Nephritis in MRL-Fas(lpr) Mice
J. Am. Soc. Nephrol.,
June 1, 2004;
15(6):
1504 - 1513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Zeiffer, A. Schober, M. Lietz, E. A. Liehn, W. Erl, N. Emans, Z.-q. Yan, and C. Weber
Neointimal Smooth Muscle Cells Display a Proinflammatory Phenotype Resulting in Increased Leukocyte Recruitment Mediated by P-Selectin and Chemokines
Circ. Res.,
April 2, 2004;
94(6):
776 - 784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang, H. Yoneyama, Y. Wang, S. Ishikawa, S.-i. Hashimoto, J.-L. Gao, P. Murphy, and K. Matsushima
Mobilization of Dendritic Cell Precursors Into the Circulation by Administration of MIP-1{alpha} in Mice
J Natl Cancer Inst,
February 4, 2004;
96(3):
201 - 209.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Eis, B. Luckow, V. Vielhauer, J. T. Siveke, Y. Linde, S. Segerer, G. P. de Lema, C. D. Cohen, M. Kretzler, M. Mack, et al.
Chemokine Receptor CCR1 But Not CCR5 Mediates Leukocyte Recruitment and Subsequent Renal Fibrosis after Unilateral Ureteral Obstruction
J. Am. Soc. Nephrol.,
February 1, 2004;
15(2):
337 - 347.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. P. Gladue, L. A. Tylaska, W. H. Brissette, P. D. Lira, J. C. Kath, C. S. Poss, M. F. Brown, T. J. Paradis, M. J. Conklyn, K. T. Ogborne, et al.
CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases
J. Biol. Chem.,
October 17, 2003;
278(42):
40473 - 40480.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Baltus, K. S. C. Weber, Z. Johnson, A. E. I. Proudfoot, and C. Weber
Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium
Blood,
September 15, 2003;
102(6):
1985 - 1988.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Schober, D. Manka, P. von Hundelshausen, Y. Huo, P. Hanrath, I. J. Sarembock, K. Ley, and C. Weber
Deposition of Platelet RANTES Triggering Monocyte Recruitment Requires P-Selectin and Is Involved in Neointima Formation After Arterial Injury
Circulation,
September 17, 2002;
106(12):
1523 - 1529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
